Arnt J. Pharmacological specificity of conditioned avoidance response inhibition in rats. Inhibition by neuroleptics and correlation to dopamine receptor blockade. Acta Pharmacol Toxicol. 51:321–329. 1982.
Article
Bartoszyk GD., Böttcher H., Seyfried CA. EMD 281014, a new selective serotonin 5-HT2A receptor antagonist. Eur J Pharmacol. 473:229–230. 2003.
Article
Carlsson A., Lindqvist M. Effect of chlorpromazine or haloperidol on the formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol (Kbh.). 20:140–144. 1963.
Cook L., Morris RW., Mattis PA. Neuropharmacological and behavioral effects of chlorpromazine (thorazine hydrochloride). J Pharmacol Exp Ther. 113:11–12. 1955.
Costentin J., Protais P., Schwartz JC. Rapid and dissociated changes in sensitivities of different dopamine receptors in mouse brain. Nature. 257:405–407. 1975.
Article
Darmani NA., Martin BR., Pandey U., Glennon RA. Do functional relationships exist between 5-HT1A and 5-HT2 receptors? Pharmacol Biochem Behav. 36:901–906. 1990.
Article
Davidson AB., Weidley E. Differential effects of neuroleptic and other psychotropic agents on acquisition of avoidance in rats. Life Sci. 18:1279–1284. 1976.
Article
Dunham NW., Miya TS. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc. 46:208–209. 1957.
Egashira N., Mishima K., Uchida T., Hasebe N., Nagai H., Mizuki A., Iwasaki K., Ishii H., Nishimura RJ., Shoyama Y., Fujiwara M. Anandamide inhibits the DOI-induced head-twitch response in mice. Psychopharmacology. 171:382–389. 2004.
Article
Gustafsson B., Christensson E. Amperozide, a new putative antipsychotic drug with a limbic mode of action on dopamine mediated behavior. Pharmacol Toxicol. 66(Suppl 1):12–17. 1990.
Kroeze WK., Hufeisen SJ., Popadak BA., Renock SM., Steinberg S., Ernsberger P., Jayathilake K., Meltzer HY., Roth BL. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology. 28:519–526. 2003.
Article
Janssen PAJ., Niemegeers CJE., Smellekens KHL. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquilizers) from animal data? Drug Res. 15:56–69. 1965.
Jones BJ., Blackburn TP. The medical benefit of 5-HT research. Pharmacol Biochem Behav. 71:555–568. 2002.
Article
Matthysse S. Antipsychotic drug actions: a clue to the pathology of schizophrenia? Fed Proc. 32:200–205. 1973.
Meltzer HY., Li Z., Kaneda Y., Ichikawa J. Serotonin receptors: their key role in drugs to treat schizophrenia. Progr Neuro Psychopharmacol Biol Psychiatr. 27:1159–1172. 2003.
Moore NA., Tye NC., Axton MS., Risius FC. The behavioral pharmacology of olanzapine, a novel “atypical” antipsychotic agent. J Pharmacol Exp Ther. 262:545–551. 1992.
Moore S., Kenyon P. Atypical antipsychotics, clozapine and sulpiride do not antagonize amphetamine-induced stereotyped locomotion. Psychopharmacology. 114:123–130. 1994.
Ogren SO., Hall H., Kohler C., Magnusson O., Lindbom LO., Angeby K., Florvall L. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain. Eur J Pharmacol. 102:459–474. 1984.
Park WK., Jeong DY., Yun CW., Lee SH., Cho HY., Kim GD., Koh HY., Pae AN., Cho YS., Choi KI., Jung JY., Jung SH., Kong JY. Pharmacological actions of a novel and selective dopamine D3 receptor antagonist, KCH-1110. Pharm Research. 48:615–622. 2003.
Article
Peroutka SJ., Snyder SH. Relationship of neuroleptic drug effects at brain dopamine, serotonin, a-adrenergic, and histamine receptors to clinical potency. Am J Psychiatry. 137:1518–1522. 1980.
Protais P., Constentin J., Schwartz JC. Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum. Psychopharmacology. 50:1–6. 1976.
Article
Protais P., Costentin J., Schwartz JC. Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum. Psychopharmacology (Berlin). 50:1–6. 1976.
Article
Reavill C., Kettle A., Holland V., Riley G., Blackburn TP. Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist. Br J Pharmacol. 126:572–574. 1999.
Article
Schreiber R., Brocco M., Audinot V., Gobert A., Veiga S., Millan MJ. (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. J Pharmacol Exp Ther. 273:101–112. 1995.
Seeman P., Van Tol HH. Dopamine receptor pharmacology. Trends Pharmacol Sci. 15:264–270. 1994.
Article
Sibley DR., Monsma Jr FJ., Shen Y. Molecular neurobiology of dopaminergic receptors. Int Rev Neurobiol. 35:391–415. 1993.
Article
Snyder SH., Banergee SP., Yamamura HI., Greenberg D. Drugs, neurotransmitters and schizophrenia. Science. 184:1243–1245. 1974.
Article
Sokoloff P., Giros B., Martres MP., Bouthenet ML., Schwartz JC. Molecular cloning and characterization of a novel dopamine receptor D3 as a target for neuroleptics. Nature. 347:146–151. 1990.
Article
Sokoloff P., Schwartz JC. Novel dopamine receptors half a decade later. Trends Pharmacol Sci. 16:270–275. 1995.
Article
Stahl SM. Psychopharmacology of antidepressants. 1st ed.Martin Dunitz Ltd;London: p. p. 31–38. 1997.
Van Rossum JM. The significance of dopamine-receptor blockade for the action of neuroleptic drugs. Arch Int Pharmacodyn Ther. 160:492–494. 1966.
Wadenberg ML., Hicks PB. The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics? Neurosci Biohav Rev. 23:851–862. 1999.
Article
Wadenberg ML., Kapur S., Soliman A., Jones C. Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats. Psychopharmacology. 150:422–429. 2000.
Willins DL., Meltzer HY. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J Pharmacol Exp Ther. 282:699–706. 1997.
Yoon BS., Park EH., Park EH., Kwon JT., Hong SB., Dong SM., Kim YH., Heo J., Ji MK., Kim YG., Kwak BS., Choi JS., Kim HT. Effects of a new antipsychotic drug (YKP1447) on impaired prepulse inhibition induced by apomorphine and phencyclidine in rats. Korean J Psychopharmacol. 19:38–45. 2008.